BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. PPARA, T cell differentiation, Influenza, Retina, Human chorionic gonadotropin)
Bookmark Forward

QuickView for cyclic peptides (compound)


Genetic Markers

Most Correlated Genes

  1. FOS
  2. DUSP1
  3. TRIB1
  4. EGR1
  5. ATF3
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. heterocyclic compound binding
  2. organic cyclic compound binding
  3. organic cyclic compound metabolic process
  4. heterocycle metabolic process
  5. PILON_KLF1_TARGETS_DN
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Genomics Assisted Toxicity Evaluation system study - Human Hepatocytes
  2. mRNA decay in MDA-MB-231 cells transfected with HNRPA2B1 siRNA
  3. Pancreatic cell lines treated with chromatin-targeting small molecules
  4. Renal mesangial cells in a time course treatment with cyclosporine A
  5. Hepatocytes treated with non-genotoxic carcinogens
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Cyclization and Self-Assembly of Cyclic Peptides.
  2. Three Methods for the Solution Phase Synthesis of Cyclic Peptides.
  3. Cyclic Peptides for the Treatment of Cancers: A Review.
  4. Molecular descriptors suggest stapling as a strategy for optimizing membrane permeability of cyclic …
  5. Solid phase diversity-oriented lysine modification of cyclic peptides.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Cit…
  2. Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbr…
  3. A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rh…
  4. NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
  5. Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors
Explore Clinical Trials Results
  • Copyright © 2023 Illumina Inc. All rights reserved.